IOL CHEMICALS AND PHARMACEUTICALS
|
IOL CHEMICALS AND PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| INCOME : | ||||
| Gross Sales | ₹2,079 Cr | ₹2,133 Cr | ₹2,217 Cr | ₹2,184 Cr |
| Sales | ₹2,068 Cr | ₹2,119 Cr | ₹2,202 Cr | ₹2,168 Cr |
| Job Work/ Contract Receipts | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - |
| Revenue from property development | - | - | - | - |
| Other Operational Income | ₹11 Cr | ₹14 Cr | ₹15 Cr | ₹16 Cr |
| Less: Excise Duty | - | - | - | - |
| Net Sales | ₹2,079 Cr | ₹2,133 Cr | ₹2,217 Cr | ₹2,184 Cr |
| EXPENDITURE : | ||||
| Increase/Decrease in Stock | ₹34 Cr | ₹-38 Cr | ₹-18 Cr | ₹-52 Cr |
| Raw Material Consumed | ₹1,358 Cr | ₹1,435 Cr | ₹1,565 Cr | ₹1,623 Cr |
| Opening Raw Materials | ₹194 Cr | ₹134 Cr | ₹243 Cr | ₹182 Cr |
| Purchases Raw Materials | ₹1,333 Cr | ₹1,495 Cr | ₹1,427 Cr | ₹1,640 Cr |
| Closing Raw Materials | ₹168 Cr | ₹194 Cr | ₹134 Cr | ₹243 Cr |
| Other Direct Purchases / Brought in cost | - | ₹0.15 Cr | ₹29 Cr | ₹44 Cr |
| Other raw material cost | - | - | - | - |
| Power & Fuel Cost | ₹115 Cr | ₹149 Cr | ₹132 Cr | ₹78 Cr |
| Electricity & Power | ₹115 Cr | ₹149 Cr | ₹132 Cr | ₹78 Cr |
| Oil, Fuel & Natural gas | - | - | - | - |
| Coals etc | - | - | - | - |
| Other power & fuel | - | - | - | - |
| Employee Cost | ₹217 Cr | ₹201 Cr | ₹168 Cr | ₹141 Cr |
| Salaries, Wages & Bonus | ₹194 Cr | ₹179 Cr | ₹150 Cr | ₹125 Cr |
| Contributions to EPF & Pension Funds | ₹15 Cr | ₹14 Cr | ₹11 Cr | ₹9.77 Cr |
| Workmen and Staff Welfare Expenses | ₹8.20 Cr | ₹8.43 Cr | ₹6.82 Cr | ₹6.25 Cr |
| Other Employees Cost | - | - | - | - |
| Other Manufacturing Expenses | ₹47 Cr | ₹48 Cr | ₹43 Cr | ₹37 Cr |
| Sub-contracted / Out sourced services | - | - | - | - |
| Processing Charges | - | - | - | - |
| Repairs and Maintenance | ₹25 Cr | ₹22 Cr | ₹13 Cr | ₹11 Cr |
| Packing Material Consumed | - | - | - | - |
| Other Mfg Exp | ₹22 Cr | ₹26 Cr | ₹30 Cr | ₹26 Cr |
| General and Administration Expenses | ₹8.10 Cr | ₹9.01 Cr | ₹6.54 Cr | ₹5.12 Cr |
| Rent , Rates & Taxes | ₹2.45 Cr | ₹2.32 Cr | ₹0.71 Cr | ₹0.62 Cr |
| Insurance | ₹5.36 Cr | ₹6.40 Cr | ₹5.54 Cr | ₹4.25 Cr |
| Printing and stationery | - | - | - | - |
| Professional and legal fees | - | - | - | - |
| Traveling and conveyance | - | - | - | - |
| Other Administration | ₹0.29 Cr | ₹0.29 Cr | ₹0.29 Cr | ₹0.25 Cr |
| Selling and Distribution Expenses | ₹62 Cr | ₹51 Cr | ₹62 Cr | ₹67 Cr |
| Advertisement & Sales Promotion | - | - | - | - |
| Sales Commissions & Incentives | - | - | - | - |
| Freight and Forwarding | ₹51 Cr | ₹42 Cr | ₹50 Cr | ₹57 Cr |
| Handling and Clearing Charges | - | - | - | - |
| Other Selling Expenses | ₹11 Cr | ₹9.61 Cr | ₹12 Cr | ₹9.50 Cr |
| Miscellaneous Expenses | ₹36 Cr | ₹47 Cr | ₹33 Cr | ₹27 Cr |
| Bad debts /advances written off | - | - | - | - |
| Provision for doubtful debts | ₹0.98 Cr | ₹0.24 Cr | ₹0.02 Cr | ₹1.27 Cr |
| Losson disposal of fixed assets(net) | ₹0.18 Cr | ₹0.04 Cr | ₹0.59 Cr | ₹1.09 Cr |
| Losson foreign exchange fluctuations | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - |
| Other Miscellaneous Expenses | ₹35 Cr | ₹47 Cr | ₹32 Cr | ₹25 Cr |
| Less: Expenses Capitalised | - | - | - | - |
| Total Expenditure | ₹1,877 Cr | ₹1,902 Cr | ₹1,991 Cr | ₹1,926 Cr |
| Operating Profit (Excl OI) | ₹202 Cr | ₹231 Cr | ₹226 Cr | ₹258 Cr |
| Other Income | ₹22 Cr | ₹30 Cr | ₹26 Cr | ₹32 Cr |
| Interest Received | ₹11 Cr | ₹14 Cr | ₹17 Cr | ₹18 Cr |
| Dividend Received | - | - | - | - |
| Profit on sale of Fixed Assets | - | ₹0.14 Cr | - | - |
| Profits on sale of Investments | - | - | - | - |
| Provision Written Back | ₹0.03 Cr | ₹0.16 Cr | ₹0.10 Cr | ₹0.10 Cr |
| Foreign Exchange Gains | ₹8.34 Cr | ₹13 Cr | ₹7.06 Cr | ₹10 Cr |
| Others | ₹3.46 Cr | ₹2.70 Cr | ₹1.72 Cr | ₹3.46 Cr |
| Operating Profit | ₹225 Cr | ₹261 Cr | ₹251 Cr | ₹290 Cr |
| Interest | ₹15 Cr | ₹16 Cr | ₹16 Cr | ₹8.29 Cr |
| InterestonDebenture / Bonds | - | - | - | - |
| Interest on Term Loan | ₹9.90 Cr | ₹11 Cr | ₹11 Cr | ₹2.25 Cr |
| Intereston Fixed deposits | - | - | - | - |
| Bank Charges etc | ₹4.86 Cr | ₹5.26 Cr | ₹5.78 Cr | ₹5.86 Cr |
| Other Interest | - | - | ₹0.07 Cr | ₹0.18 Cr |
| PBDT | ₹210 Cr | ₹245 Cr | ₹235 Cr | ₹282 Cr |
| Depreciation | ₹72 Cr | ₹63 Cr | ₹46 Cr | ₹43 Cr |
| Profit Before Taxation & Exceptional Items | ₹138 Cr | ₹182 Cr | ₹189 Cr | ₹239 Cr |
| Exceptional Income / Expenses | - | - | - | ₹-14 Cr |
| Profit Before Tax | ₹138 Cr | ₹182 Cr | ₹189 Cr | ₹225 Cr |
| Provision for Tax | ₹37 Cr | ₹47 Cr | ₹50 Cr | ₹57 Cr |
| Current Income Tax | ₹23 Cr | ₹37 Cr | ₹45 Cr | ₹57 Cr |
| Deferred Tax | ₹12 Cr | ₹10 Cr | ₹3.25 Cr | ₹0.17 Cr |
| Other taxes | ₹2.09 Cr | ₹-0.03 Cr | ₹1.32 Cr | ₹-0.22 Cr |
| Profit After Tax | ₹101 Cr | ₹134 Cr | ₹139 Cr | ₹168 Cr |
| Extra items | - | - | - | - |
| Minority Interest | - | - | - | - |
| Share of Associate | - | - | - | - |
| Other Consolidated Items | - | - | - | - |
| Consolidated Net Profit | ₹101 Cr | ₹134 Cr | ₹139 Cr | ₹168 Cr |
| Adjustments to PAT | - | - | - | - |
| Profit Balance B/F | ₹1,324 Cr | ₹1,219 Cr | ₹1,104 Cr | ₹971 Cr |
| Appropriations | ₹1,426 Cr | ₹1,354 Cr | ₹1,243 Cr | ₹1,139 Cr |
| General Reserves | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - |
| Corporate dividend tax | - | - | - | - |
| Other Appropriation | - | - | ₹0.02 Cr | ₹12 Cr |
| Equity Dividend % | ₹40.00 | ₹50.00 | ₹40.00 | ₹40.00 |
| Earnings Per Share | ₹3.44 | ₹22.90 | ₹23.70 | ₹28.56 |
| Adjusted EPS | ₹3.44 | ₹4.58 | ₹4.74 | ₹5.71 |
Compare Income Statement of peers of IOL CHEMICALS AND PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IOL CHEMICALS AND PHARMACEUTICALS | ₹2,413.7 Cr | -0.3% | -10.1% | -4.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
IOL CHEMICALS AND PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IOL CHEMICALS AND PHARMACEUTICALS | -0.3% |
-10.1% |
-4.6% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses